Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine

References

• Agnihotri SA, Aminabhavi TM. 2004. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Control Release. 96:245–259.
   PubMed Web of Science ®Google Scholar
• Bellringer ME, Smith TG, Read R, Gopinath C, Olivier P. 1995. β-Cyclodextrin: 52-week toxicity studies in the rat and dog. Food Chem Toxicol. 33:367–376.
   PubMed Web of Science ®Google Scholar
• Cappello B, Carmignani C, Iervolino M, Immacolata La Rotonda M, Fabrizio Saettone M. 2001. Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: in vitro/in vivo studies. Int J Pharm. 213:75–81.
   PubMed Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. 2007. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release. 123:78–99.
   PubMed Web of Science ®Google Scholar
• Fischer V, Haar JA, Greiner L, Lloyd RV, Mason RP. 1991. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. Mol Pharmacol. 40:846–853.
   PubMed Web of Science ®Google Scholar
• Hanawa K, Hanawa T, Tsuchiya C, Higashi K, Suzuki M, Moribe K, Yamamoto K, Oguchi T. 2010. Development of sarpogrelate external preparation for intractable pain control. I. Pre-formulation study on application of modified beta-cyclodextrins. Chem Pharm Bull. 58:45–50.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instr. 4:117–212.
   Google Scholar
• Irie T, Uekama K. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 86:147–162.
   PubMed Web of Science ®Google Scholar
• Ishiguro T, Morishita E, Iohara D, Hirayama F, Wada K, Motoyama K, Arima H, Uekama K. 2011. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative. Int J Pharm. 419:161–169.
   PubMed Web of Science ®Google Scholar
• Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. 2011. Sulfobutyl ether7 β-cyclodextrin (SBE7 β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS PharmSciTech. 12:1163–1175.
   PubMed Web of Science ®Google Scholar
• Jann MW, Grimsley SR, Gray EC, Chang WH. 1993. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet. 24:161–176.
   PubMed Web of Science ®Google Scholar
• Job P. 1928. Formation and stability of inorganic complexes in solution. Ann Chim. 9:113–203.
   Google Scholar
• Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T. 2009. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology. 34:118–128.
   PubMed Web of Science ®Google Scholar
• Kurkov SV, Loftsson T. 2013. Cyclodextrins. Int J Pharm. 453:167–180.
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Choi S, Lee J, Nguyen NT, Lee K, Kang JS, Mar W, Kim KH. 2012. Chiral discrimination of sibutramine enantiomers by capillary electrophoresis and proton nuclear magnetic resonance spectroscopy. Arch Pharm Res. 35:671–681.
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. 2004. Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 58:265–278.
   PubMed Web of Science ®Google Scholar
• Loftsson T. 1998. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie. 53:733–740.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 85:1017–1025.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. 2012. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 101:3019–3032.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Frikdriksdóttir H, Sigurkdardóttir AM, Ueda H. 1994. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm. 110:169–177.
   Web of Science ®Google Scholar
• Loftsson T, Hreinsdottir D, Masson M. 2005. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 302:18–28.
   PubMed Web of Science ®Google Scholar
• Martins MH, Calderini A, Pessine FBT. 2012. Host–guest interactions between dapsone and β-cyclodextrin (Part II): thermal analysis, spectroscopic characterization, and solubility studies. J Incl Phenom Macrocycl Chem. 74:109–116.
   Web of Science ®Google Scholar
• Ogawa N, Takahashi C, Yamamoto H. 2015. Physicochemical characterization of cyclodextrin-drug interactions in the solid state and the effect of water on these interactions. J Pharm Sci. 104:942–954.
   PubMed Web of Science ®Google Scholar
• Pawar SN, Edgar KJ. 2012. Alginate derivatization: a review of chemistry, properties and applications. Biomaterials. 33:3279–3305.
   PubMed Web of Science ®Google Scholar
• Phillip Lee YH, Sathigari S, Jean Lin YJ, Ravis WR, Chadha G, Parsons DL, Rangari VK, Wright N, Babu RJ. 2009. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Dev Ind Pharm. 35:1113–1120.
   PubMed Web of Science ®Google Scholar
• Qu Q, Tucker E, Christian SD. 2002. Sulfoalkyl ether β-cyclodextrin derivatives: synthesis and characterizations. J Incl Phenom Macrocycl Chem. 43:213–221.
   Web of Science ®Google Scholar
• Savic IM, Savic-Gajic IM, Nikolic VD, Nikolic LB, Radovanovic BC, Milenkovic-Andjelkovic A. 2016. Enhancement of solubility and photostability of rutin by complexation with β-cyclodextrin and (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 86:33–43.
   Web of Science ®Google Scholar
• Savic-Gajic I, Savic IM, Nikolic VD, Nikolic LB, Popsavin MM, Kapor AJ. 2016. Study of the solubility, photostability and structure of inclusion complexes of carvedilol with β-cyclodextrin and (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 86:7–17.
   Web of Science ®Google Scholar
• Savic IM, Nikolic VD, Savic-Gajic I, Nikolic LB, Radovanovic BC, Mladenovic JD. 2015. Investigation of properties and structural characterization of the quercetin inclusion complex with (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 82:383–394.
   Web of Science ®Google Scholar
• Savić-Gajić I, Savić IM, Nikolić VD, Nikolić LB, Popsavin MM, Rakić SJ. 2017. The improvement of photostability and antioxidant activity of trans-resveratrol by cyclodextrins. Adv Techol. 6:18–25.
   Google Scholar
• Schaber G, Wiatr G, Wachsmuth H, Dachtler M, Albert K, Gaertner I, Breyer-Pfaff U. 2001. Isolation and identification of clozapine metabolites in patient urine. Drug Metab Dispos. 29:923–931.
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Hacket F, Rudiger V, Ikeda H. 1998. NMR Studies of cyclodextrins and cyclodextrin complexes. Chem Rev. 98:1755–1786.
   PubMed Web of Science ®Google Scholar
• Shen M, Wu M, Tan X, Song Z. 2013. Study on the inclusion interaction between sulfobutylether-β-cyclodextrin and clozapine by flow injection chemiluminescence. Instrum Sci Technol. 42:46–58.
   Web of Science ®Google Scholar
• Tačić A, Savić I, Nikolić V, Savić I, Ilić-Stojanović S, Ilić D, Petrović S, Popsavin M, Kapor A. 2014. Inclusion complexes of sulfanilamide with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 80:113–124.
   Web of Science ®Google Scholar
• Usuda M, Endo T, Nagase H, Tomono K, Ueda H. 2000. Interaction of antimalarial agent artemisinin with cyclodextrins. Drug Dev Ind Pharm. 26:613–619.
   PubMed Web of Science ®Google Scholar
• Zeng F, Wang L, Zhang W, Shi K, Zong L. 2013. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes. AAPS PharmSciTech. 14:854–860.
   PubMed Web of Science ®Google Scholar
• Zhu X, Tan W, Zhou F, Li Z, Duan L. 2012. The effect of phosphate buffer solutions on uniconazole complexation with hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 73:193–198.
   Web of Science ®Google Scholar